Vanilmandelic Acid - Metabolism
Research News and Information

Sunday, November 22, 2009

[Biological diagnosis of pheochromocytomas and paragangliomas]

7 Jan 2009 Pheochromocytomas and/or paragangliomas are rare, heterogeneous tumors of the chromaffin cells. Thirty percent of the patients presented with these diseases in a hereditary context. The biological diagnosis relies on the identification of excessive ... Read more...

Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.

29 Nov 2003 The purpose of the present study was to elucidate the expression of human organic anion transporter 1 (hOAT1) and hOAT3 in the choroid plexus of the human brain and their interactions with neurotransmitter metabolites using stable cell lines. ... Read more...

The use of enzyme immunoassays for the detection of abzymatic activities. Application to an enantioselective thioacetal hydrolysis activity.

30 Oct 2002 Relying on the particularly high specificity displayed by antibodies, enzyme immunoassays have proved to be one of the most efficient tools for early detection of the catalytic activities displayed by antibodies. We took advantage of such an assay, ... Read more...

Latest indexed articles for 'Vanilmandelic Acid - Metabolism'

These are the very latest articles for this heading:

• [Biological diagnosis of pheochromocytomas and paragangliomas] 7 Jan 2009
• [Vanillylmandelic acid (VMA) and homovanillic acid (HVA)] 30 Jul 2005
• Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. 29 Nov 2003
• The use of enzyme immunoassays for the detection of abzymatic activities. Application to an enantioselective thioacetal hydrolysis activity. 30 Oct 2002
• Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion. 27 Feb 2001
• Induction of catecholamine synthesis in human neuroblastoma cells by replication inhibitors and sodium butyrate. 30 Sep 1999
• [Effects of aluminum on neurobehavioral function and metabolism of monoamine neurotransmitter] 27 Feb 1998
• Phaeochromocytoma: how to catch a moonbeam in your hand. 30 Dec 1996
• Metabolic characterisation of a novel vanillylmandelate-degrading bacterium. 29 Sep 1996
• Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia. 30 May 1996
• Urinary homovanillic acid and vanillylmandelic acid in workers exposed to carbon disulfide. 28 Feb 1996
• Noradrenergic and adrenergic functioning in autism. 13 Aug 1994
• [Basic and clinical studies of pheochromocytoma with special reference to recent data obtained from our laboratory] 30 Dec 1993
• [The neurohumoral status in depression] 29 Jun 1993
• Effects of S-11701 on accumulation, release and metabolism of norepinephrine in isolated canine saphenous veins. 30 Oct 1992
• Effects of N-ethyl,N-nitrosourea on monoamine concentrations and metabolizing enzymes in mouse brain regions. 29 Apr 1992
• Activity of the sympathoadrenal system in cosmonauts during 25-day space flight on station Mir. 30 Dec 1990
• Functionally active ganglioneuroma with increased plasma and urinary catecholamines and positive iodine 131-meta-iodobenzylguanidine scintigraphy. 30 Dec 1990
• Hypothalamic-pituitary-adrenocortical axis activity and immune function after oral exposure to benzene and toluene. 30 Dec 1990
• Asymptomatic adrenal tumor; 386 cases in Japan including our 7 cases. 29 Sep 1990

See a longer list of these articles.

Technical information about 'Vanilmandelic Acid'

Chemical name: Benzeneacetic acid, alpha,4-dihydroxy-3-methoxy-

Registry Number: 55-10-7

Descriptor UI: D014642

Alternative terms: Vanilmandelic Acid; Acid, Vanilmandelic; Vanillylmandelic Acid; Acid, Vanillylmandelic; 4-Hydroxy-3-Methoxymandelic Acid; 4 Hydroxy 3 Methoxymandelic Acid; Acid, 4-Hydroxy-3-Methoxymandelic; Methoxyhydroxymandelic Acid; Acid, Methoxyhydroxymandelic;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.241.223.475.730; D02.241.511.536.730;

History Note: 72(68)